Tackling myocardial oxidative stress with empagliflozin: are we big enough to fight heart failure with preserved ejection fraction?
作者信息
Paneni Francesco, Sciarretta Sebastiano, Costantino Sarah
机构信息
Center for Molecular Cardiology, University of Zürich, Wagistrasse 12, Schlieren, CH-8952, Switzerland.
University Heart Center, Cardiology, University Hospital Zurich, Switzerland.
出版信息
Cardiovasc Res. 2021 Jan 21;117(2):343-345. doi: 10.1093/cvr/cvaa196.
PMID:32637983
Abstract
摘要
相似文献
1
Tackling myocardial oxidative stress with empagliflozin: are we big enough to fight heart failure with preserved ejection fraction?用恩格列净应对心肌氧化应激：我们是否有足够的能力对抗射血分数保留的心力衰竭？
Cardiovasc Res. 2021 Jan 21;117(2):343-345. doi: 10.1093/cvr/cvaa196.
2
Empagliflozin Reverses Late Na Current Enhancement and Cardiomyocyte Proarrhythmia in a Translational Murine Model of Heart Failure With Preserved Ejection Fraction.恩格列净可逆转射血分数保留的心力衰竭小鼠转化模型中的晚期钠电流增强和心肌细胞致心律失常作用。
Circulation. 2022 Mar 29;145(13):1029-1031. doi: 10.1161/CIRCULATIONAHA.121.057237. Epub 2022 Mar 28.
3
Research in brief: Empagliflozin for patients with heart failure and preserved ejection fraction.简要研究：恩格列净用于射血分数保留的心力衰竭患者。
Clin Med (Lond). 2022 Jan;22(1):75-76. doi: 10.7861/clinmed.rib.22.1.1.
4
Evidence for empagliflozin in heart failure with preserved ejection fraction (HFpEF).恩格列净在射血分数保留型心力衰竭（HFpEF）中的证据。
Drug Ther Bull. 2023 Feb;61(2):22-23. doi: 10.1136/dtb.2022.000060. Epub 2022 Dec 12.
5
Empagliflozin in Heart Failure with a Preserved Ejection Fraction.恩格列净用于射血分数保留的心力衰竭
N Engl J Med. 2022 May 26;386(21):e57. doi: 10.1056/NEJMc2118470.
6
Empagliflozin in Heart Failure with a Preserved Ejection Fraction.恩格列净用于射血分数保留的心力衰竭
N Engl J Med. 2022 May 26;386(21):e57. doi: 10.1056/NEJMc2118470.
7
Empagliflozin in Heart Failure with a Preserved Ejection Fraction.恩格列净用于射血分数保留的心力衰竭
N Engl J Med. 2022 May 26;386(21):e57. doi: 10.1056/NEJMc2118470.
8
Empagliflozin in Heart Failure with a Preserved Ejection Fraction.恩格列净用于射血分数保留的心力衰竭
N Engl J Med. 2022 May 26;386(21):e57. doi: 10.1056/NEJMc2118470.
9
A Dose Comparison Study of Empagliflozin in Patients With Heart Failure With Preserved Ejection Fraction.恩格列净治疗射血分数保留的心力衰竭患者的剂量比较研究
Can J Cardiol. 2024 Mar;40(3):388. doi: 10.1016/j.cjca.2023.05.018. Epub 2023 Jun 2.
10
Empagliflozin in Heart Failure with a Preserved Ejection Fraction. Reply.恩格列净用于射血分数保留的心力衰竭。回复
N Engl J Med. 2022 May 26;386(21):e57. doi: 10.1056/NEJMc2118470.
引用本文的文献
1
Ferroptosis: The Potential Target in Heart Failure with Preserved Ejection Fraction.铁死亡：射血分数保留型心力衰竭的潜在靶点。
Cells. 2022 Sep 12;11(18):2842. doi: 10.3390/cells11182842.
2
Cardiovascular protection by SGLT2 inhibitors - Do anti-inflammatory mechanisms play a role?SGLT2 抑制剂的心血管保护作用——抗炎机制是否发挥作用？
Mol Metab. 2022 Oct;64:101549. doi: 10.1016/j.molmet.2022.101549. Epub 2022 Jul 18.
Zotero 插件